Ceric S, Ceric T, Pojskic N, Bilalovic N, Musanovic J, Kucukalic-Selimovic E
University Clinical Center Sarajevo. Bosnia and Herzegovina - Department of Nuclear Medicine and Endocrinology - Sarajevo, Bosnia and Herzegovina.
University Clinical Center Sarajevo. Bosnia and Herzegovina - Department of Oncology - Sarajevo, Bosnia and Herzegovina.
Acta Endocrinol (Buchar). 2020 Oct-Dec;16(4):409-416. doi: 10.4183/aeb.2020.409.
Neoangiogenesis and lymphangio-genesis are essential for the growth of tumor and progression of malignancy.
The study examined the significance of VEGF-C expression in comparison to classical prognostic factors in differentiated thyroid carcinoma (DTC), as well as an independent prognostic marker in DTC.
The study included 81 patients with DTC allocated in two groups according to the type of cancer (follicular papillary) and then compared to expression of VEGF-C and clinicopathological features.
Expression of VEGF-C was identified with anti-VEGF-C antibody using tris-EDTA buffer Antigen Retrieval Protocol. Each specimen was scored with a semi-quantitative score system (H-score).
The analysis of T staging system showed a linear correlation between the size of a tumor, expression of VEGF-C and recurrence of a disease, with a statistical significance (p < 0.0001). There was a clear and significant correlation between VEGF-C expression and T stage in patients with papillary carcinoma (p = 0.0294). Analysis of invasion of a surgical margin demonstrated significant positivity in patients with papillary thyroid cancers who expressed VEGF-C (p = 0.0207) indicating the worse prognosis of a disease. Also a statistically significant correlation was between VEGF-C and extrathyroid extension, indicating the worse prognosis (p = 0.0133) in papillary cancers. The level of VEGF-C expression was statistically significant in patients with papillary thyroid cancer (p = 0.039).
This study undoubtedly demonstrates that VEGF-C expression is an evident negative prognostic factor in patients with papillary thyroid carcinoma, along with the classic prognostic factors, such as a larger tumor size, tumor margin involvement, extrathyroid extension, i.e. local aggressiveness.
新生血管生成和淋巴管生成对于肿瘤生长及恶性进展至关重要。
本研究探讨了血管内皮生长因子C(VEGF-C)表达相对于分化型甲状腺癌(DTC)经典预后因素的意义,以及其作为DTC独立预后标志物的价值。
本研究纳入81例DTC患者,根据癌症类型(滤泡型、乳头状)分为两组,然后比较VEGF-C表达与临床病理特征。
使用三羟甲基氨基甲烷-乙二胺四乙酸(Tris-EDTA)缓冲液抗原修复方案,用抗VEGF-C抗体鉴定VEGF-C表达。每个标本采用半定量评分系统(H评分)进行评分。
T分期系统分析显示,肿瘤大小、VEGF-C表达与疾病复发之间存在线性相关性,具有统计学意义(p < 0.0001)。乳头状癌患者中,VEGF-C表达与T分期之间存在明显且显著的相关性(p = 0.0294)。手术切缘浸润分析显示,表达VEGF-C的甲状腺乳头状癌患者阳性率显著(p = 0.0207),表明疾病预后较差。VEGF-C与甲状腺外侵犯之间也存在统计学显著相关性,表明乳头状癌预后较差(p = 0.0133)。甲状腺乳头状癌患者VEGF-C表达水平具有统计学意义(p = 0.039)。
本研究无疑表明,VEGF-C表达是甲状腺乳头状癌患者明显的负性预后因素,与经典预后因素如肿瘤较大、肿瘤边缘受累、甲状腺外侵犯即局部侵袭性一样。